Cargando…
The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients
A thorough study of the exosomal proteomic cargo may enable the identification of proteins that play an important role in cancer development. The aim of this study was to compare the protein profiles of the serum exosomes derived from non-small lung cancer (NSCLC) patients and healthy volunteers (co...
Autores principales: | Baran, Kamila, Waśko, Joanna, Kryczka, Jakub, Boncela, Joanna, Jabłoński, Sławomir, Kolesińska, Beata, Brzeziańska-Lasota, Ewa, Kordiak, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650331/ https://www.ncbi.nlm.nih.gov/pubmed/37761972 http://dx.doi.org/10.3390/ijms241813669 |
Ejemplares similares
-
Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene—Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC
por: Kryczka, Jolanta, et al.
Publicado: (2022) -
The Significance of the Alter miR let-7a and miR-335 Expression Level Regulating the CCR7/CCL19 Axis as Potential Biomarkers of Tumor Progression in NSCLC
por: Baran, Kamila, et al.
Publicado: (2022) -
Panel of miR-150 and linc00673, regulators of CCR6/CCL20 may serve as non-invasive diagnostic marker of non-small cell lung cancer
por: Baran, Kamila, et al.
Publicado: (2023) -
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
por: Kryczka, Jolanta, et al.
Publicado: (2021) -
Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers
por: Kryczka, Jolanta, et al.
Publicado: (2021)